The purpose of this study is to gather information about the safety and effectiveness of the non-pharmacological (non-drug), non-invasive treatment known as low-frequency pulsed electromagnetic field (PEMF) therapy. The study team will distribute the PEMF device to female adults with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) to measure its ability to decrease bladder and pelvic pain as well as other urinary symptoms associated with IC/BPS. There are two sequential Aims in this study and subjects will be recruited to participate in only one Aim. In both Aims, data will be collected at baseline/enrollment, 4-weeks after using PEMF therapy, and 8, 12, and 16 weeks post-enrollment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Pelvic pain, as measured by the Brief Pain Inventory (BPI) Short Form
Timeframe: Baseline
Change from baseline pelvic pain, as measured by the Brief Pain Inventory (BPI) Short Form
Timeframe: Week 4
Change from baseline pelvic pain, as measured by the Brief Pain Inventory (BPI) Short Form
Timeframe: Week 8
Change from baseline pelvic pain, as measured by the Brief Pain Inventory (BPI) Short Form
Timeframe: Week 12
Change from baseline pelvic pain, as measured by the Brief Pain Inventory (BPI) Short Form
Timeframe: Week 16